Death induced by CD95 or CD95 ligand elimination Journal Article


Authors: Hadji, A.; Ceppi, P.; Murmann, A. E.; Brockway, S.; Pattanayak, A.; Bhinder, B.; Hau, A.; De Chant, S.; Parimi, V.; Kolesza, P.; Richards, J.; Chandel, N.; Djaballah, H.; Peter, M. E.
Article Title: Death induced by CD95 or CD95 ligand elimination
Abstract: CD95 (Fas/APO-1), when bound by its cognate ligand CD95L, induces cells to die by apoptosis. We now show that elimination of CD95 or CD95L results in a form of cell death that is independent of caspase-8, RIPK1/MLKL, and p53, is not inhibited by Bcl-xL expression, and preferentially affects cancer cells. All tumors that formed in mouse models of low-grade serous ovarian cancer or chemically induced liver cancer with tissue-specific deletion of CD95 still expressed CD95, suggesting that cancer cannot form in the absence of CD95. Death induced by CD95R/L elimination (DICE) is characterized by an increase incell size, production of mitochondrial ROS, and DNA damage. It resembles a necrotic form of mitotic catastrophe. No single drug was found to completely block this form of cell death, and it could also not be blocked by the knockdown of a single gene, making it a promising way to kill cancer cells. © 2014 The Authors.
Journal Title: Cell Reports
Volume: 7
Issue: 1
ISSN: 2211-1247
Publisher: Cell Press  
Date Published: 2014-04-10
Start Page: 208
End Page: 222
Language: English
DOI: 10.1016/j.celrep.2014.02.035
PROVIDER: scopus
PUBMED: 24656822
PMCID: PMC4083055
DOI/URL:
Notes: Export Date: 1 May 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bhavneet Bhinder
    31 Bhinder
  2. Hakim Djaballah
    101 Djaballah